I'm one of them, and as I can attest, the results can be dramatic: In clinical trials, people taking these medications often lose a substantial amount of weight, though outcomes vary by drug, dose and individual
However, there are considerable risks, demonstrated by clinical reports, of unappreciated high volumes of gastric contents even when fasting guidelines are followed
Multiple users report significant weight loss
However, attorneys are monitoring emerging research and may pursue further legal action if stronger evidence ties oral health damage to GLP-1 medications
Back Braun, K, von Voss, P, Gotfredsen, CF, et al (1 Jan 2007) 'Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-iv inhibitor, vildagliptin, does not', Diabetes , 56/1, 815
Even the patients who have been doing really well for years and years, I have to see them at least once a year because any life stressor can shake up their journey, she says